CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project aims to enhance the viability of marginal kidneys from older donors for transplantation by using adipose-derived regenerative cells. Through advanced imaging and machine perfusion techniques, it seeks to assess the therapeutic effects of these cells on kidney function, potentially improving outcomes for pat…
Kidney transplantation is the gold-standard for end-stage kidney disease (ESKD) but there is a shortage of organs.
To increase organ numbers, kidneys from deceased donors aged over 60 are now often used.
These so-called “marginal” kidneys are susceptible to the ischemic tissue damage that occurs during transplantation, and tend not to function as well, nor last as long, as kidneys from younger donors.
Cell therapies administered into the renal artery prior to transplantation have potential to re…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, Swansea
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
